SCHEDULE: Durable Capital Partners Discloses 7.8% Stake in Evolent Health
Beneficial Ownership Report
Durable Capital Partners LP has reported a significant beneficial ownership stake of 7.8% in Evolent Health, Inc., holding over 9.1 million shares of Class A Common Stock.
Summary
- Durable Capital Partners LP, an investment adviser, has filed a Schedule 13G indicating beneficial ownership of 9,118,912 shares of Evolent Health, Inc.'s Class A Common Stock.
- This ownership represents 7.8% of the outstanding Class A Common Stock, based on 117,399,810 shares outstanding as of May 2, 2025.
- Durable Capital Partners LP, as the investment adviser to Durable Capital Master Fund LP, holds sole voting and dispositive power over all 9,118,912 shares.
- The filing was made under Rule 13d-1(b), indicating that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 6
Explanation: The document is a factual disclosure of beneficial ownership. While the acquisition of a significant stake by an institutional investor can be viewed positively, the document itself contains no operational or financial performance data to assess sentiment beyond the ownership change.
Positives
- The disclosure of a significant stake by an institutional investor like Durable Capital Partners LP may signal confidence in Evolent Health's long-term prospects.
- The filing indicates that the stake was acquired in the ordinary course of business, suggesting a passive investment rather than an activist intent to disrupt management.
Negatives
- The document does not contain information that can be categorized as negatives regarding Evolent Health's operations or financial performance.
Risks
- The document does not detail specific risks related to Evolent Health's operations or financial health, focusing solely on beneficial ownership disclosure.
Future Outlook
The document does not provide any forward-looking statements or guidance regarding Evolent Health's future performance or strategic direction.
Industry Context
This filing reflects an investment by a capital management firm in a healthcare technology company. Such investments are common as institutional investors seek exposure to sectors with growth potential, like healthcare IT, which is undergoing significant transformation.
Comparison to Industry Standards
- NA
Stakeholder Impact
- Shareholders: The disclosure of a new significant institutional holder may influence investor perception and potentially the stock's trading activity.
- Company Management: Awareness of a large, passive institutional investor on the shareholder register.
Key Dates
| Date | Description |
|---|---|
| 2025-05-02 | Date as of which 117,399,810 Class A Common Stock shares were reported outstanding in Evolent Health's Schedule 10-Q. |
| 2025-05-09 | Date Evolent Health's Schedule 10-Q was filed with the SEC, reporting outstanding shares. |
| 2025-06-27 | Date of event which required the filing of this Schedule 13G statement. |
| 2025-07-07 | Date the Schedule 13G statement was signed by Durable Capital Partners LP. |
Keywords
Evolent Health, Durable Capital Partners, Beneficial Ownership, SEC Filing, Schedule 13G, Class A Common Stock, Investment Adviser, Healthcare Technology, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.